Page 1. Contains Nonbinding Recommendations Draft Guidance on Megestrol Acetate ... Active ingredient: Megestrol Acetate Form/Route: Suspension/Oral ...
Center for Drug Evaluation (CDER)
...administered orally or parenterally to animals may induce the first stage...metritis. (2) Systemic therapy with methylprednisolone acetate...corticoids, is contraindicated in animals with arrested tuberculosis...Appropriate antibacterial therapy should be instituted...
Code of Federal Regulations, 2011
HIV Infections; Unintended Weight Loss; Cachexia; Anorexia; AIDS Wasting Syndrome; HIV Wasting Syndrome
ClinicalTrials.gov
... false Dihydrostreptomycin oral suspension. 520.2158c...ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED...FEEDS, AND RELATED PRODUCTS ORAL DOSAGE FORM NEW ANIMAL DRUGS...2158c Dihydrostreptomycin oral suspension. (a)...
...2010-04-01 false Sulfadimethoxine oral suspension. 520.2220c Section 520.2220c Food...DRUGS § 520.2220c Sulfadimethoxine oral suspension. (a) Chemical name. N...
Code of Federal Regulations, 2010
... product shortage, although it will not immediately resolve shortages in all areas and availability of Tamiflu for Oral Suspension may be variable for some time ...
Page 1. Contains Nonbinding Recommendations Draft Guidance on Calcium Acetate ... Active ingredient: Calcium Acetate Form/Route: Capsules/Oral ...
Center for Biologics Evaluation and Research (CBER)
Page 1. Contains Nonbinding Recommendations Draft Guidance on Calcium Acetate ... Active ingredient: Calcium Acetate Form/Route: Tablets/Oral ...
A randomized, double-blind, placebo-controlled phase III clinical trial was performed to assess megestrol acetate (Megace) as a postsurgical adjuvant therapy for patients with locally advanced malignant melanoma. Patients whose tumors were greater than 1.7 mm thick and had no regional lymph node involvement and patients with regional lymph node involvement were randomized to ...
PubMed
